Skip to content
Unrated Medical device recall · FDA · Published April 21, 2021

Boston Scientific ELUVIA Stent Recall: Incorrect Packaging May Cause Misplacement

Boston Scientific recalls ELUVIA Drug-Eluting Vascular Stents due to incorrect packaging that may lead to stent misplacement during procedures. Affected units have specific lot numbers.

🇺🇸 FDA recall #Z-1621-2021Medical deviceBoston Scientific ›
Take action

Contact the company

Recalling firmBoston Scientific Corporation1 Scimed Pl · Maple Grove, MN 55311-1565
✎ GovInfoNow plain-language explainer

What happened, in plain English

Boston Scientific is recalling ELUVIA Drug-Eluting Vascular Stents because some units were packaged incorrectly, potentially causing stents to be placed in the wrong size. This could lead to improper treatment of blood vessels and complications during procedures. Read more at govinfonow.com/recall/62759-boston-scientific-eluvia-stent-recall-incorrect-packaging-may-cause-misplacement.

Source Summary by GovInfoNow · govinfonow.com/recall/62759-boston-scientific-eluvia-stent-recall-incorrect-packaging-may-cause-misplacement · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1621-2021

Cite this page

“Boston Scientific ELUVIA Stent Recall: Incorrect Packaging May Cause Misplacement.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62759-boston-scientific-eluvia-stent-recall-incorrect-packaging-may-cause-misplacement. Based on FDA recall #Z-1621-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1621-2021%22&limit=1).

Why it’s dangerous

The stents were incorrectly placed in 6x100mm packaging instead of 6x40mm. This could cause the stent to be too large for the blood vessel, leading to improper treatment or complications during procedures.

Who’s affected

Patients who received the ELUVIA stent system with lot number 25838357 are affected. Medical professionals using this specific batch for procedures are at higher risk.

How to tell if you have this one

Check for the lot number 25838357 on the packaging. The ELUVIA stent system is used for treating blood vessels in the leg and is sold by Boston Scientific.

  • Brand
    Boston Scientific
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Packaging

    Look for the lot number 25838357 on the ELUVIA stent packaging.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 22 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: nationwideGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: nationwideFLPuerto Rico: named in the noticePR

FDA distribution: “US Nationwide distribution in the states of AL, AR, AZ, CA, DE, HI, IL, KS, KY, MA, MD, NC, NJ, NV, NY, OH, OK, PA,PR, TX, VA,WA,WV.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Delaware, Hawaii, Illinois, Kansas, Kentucky, Maryland, Massachusetts, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Texas, Virginia, Washington, West Virginia.

Recall timeline

FDA terminated this recall 2.3 years after the firm started it.

1. Firm started the recall: Apr 21, 202112. FDA classified it Class II: May 18, 202123. Published in FDA’s Enforcement Report: May 26, 202134. FDA terminated the recall: Aug 7, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1621-2021 (April 21, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1621-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA